|
|
|
|
| LEADER |
00000cam a22000002 4500 |
| 001 |
109155191X |
| 003 |
DE-627 |
| 005 |
20230426064227.0 |
| 007 |
tu |
| 008 |
900910s1980 xx ||||| 00| ||eng c |
| 024 |
8 |
|
|a SNAC-96-2-16
|q Sonstige Nr.
|
| 035 |
|
|
|a (DE-627)109155191X
|
| 035 |
|
|
|a (DE-576)02155191X
|
| 035 |
|
|
|a (DE-599)BSZ02155191X
|
| 035 |
|
|
|a (OCoLC)07264874
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
|
|a 363.4/5/0973
|
| 245 |
1 |
0 |
|a Oversight on federal drug strategy-1979
|b a report of the select Committee on Narcotics Abuse and Control, ninety-sixth Congress, second session
|
| 264 |
|
1 |
|a Washington, D.C.
|b U.S. Gov. Pr. Office
|c 1980
|
| 300 |
|
|
|a IV, 63 p.
|b ill.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 1
|2 pdager
|
| 710 |
2 |
|
|a USA
|b Congress
|b House of Representatives
|b Select Committee on Narcotics Abuse and Control
|0 (DE-588)1048583-1
|0 (DE-627)100142443
|0 (DE-576)191429007
|4 oth
|
| 951 |
|
|
|a BO
|
| ELC |
|
|
|b 1
|
| LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
| LOK |
|
|
|0 001 2150547546
|
| LOK |
|
|
|0 003 DE-627
|
| LOK |
|
|
|0 004 109155191X
|
| LOK |
|
|
|0 005 20020606000000
|
| LOK |
|
|
|0 008 900910||||||||||||||||ger|||||||
|
| LOK |
|
|
|0 040
|a DE-21
|c DE-627
|d DE-21
|
| LOK |
|
|
|0 852
|a DE-21
|
| LOK |
|
|
|0 852 1
|c KB 4 E 32
|9 00
|
| LOK |
|
|
|0 935
|a krim
|
| LOK |
|
|
|0 936ln
|a k9.7.2.2
|
| ORI |
|
|
|a SA-MARC-krimdoka001.raw
|
| SIG |
|
|
|a UB: KB 4 E 32
|
